Loading...

Upcoming Events

5th International Conference on Developmental Neurotoxicity Testing (DNT)

April 7-10, 2024 | Konstanz, Germany

Neurosetta is sponsoring, exhibiting, and presenting.

MPS World Summit 2024

June 10-14, 2024 | Seattle Convention Center – Summit Building, Seattle, Washington

Neurosetta is sponsoring, exhibiting, and presenting.

Fetal brain and spinal cord
Rosette
RosetteArray Logo

Human Neurodevelopmental Screening, Simplified

Bring embryonic neurodevelopment within reach for scientific screening and discovery with RosetteArray® technology (Patent No. US 11,767,508). RosetteArray assays model embryonic brain and spinal cord development in micropatterned well plate culture, and assess substances or genetic backgrounds for risk of developmental disruptions, including developmental neurotoxicity or neurodevelopmental disorders.

Protecting human health is easier than ever before with RosetteArray technology.

Funding

Wisconsin Alumni Research Foundation (WARF) logo

The founding of Neurosetta was supported by the WARF Accelerator Program. 

Center for Technology Commercialization Logo
National Institute of Environmental Health Sciences Logo

Collaborators

University of Wisconsin, Ashton Lab

Neural Tube Defect/Spina Bifida Risk Screening

Shchlegovitov Lab, University of Utah

Scalable Cortical Organoid Manufacture

Di Angelantonio Lab, Sapienza University of Rome

Tauopathy Screening

Florida State University, Standwood Lab

Neurodevelopmental Effects of Opioid Exposure

UC Santa Cruz Shariati Lab

Mouse and Human Embryoid Modeling

EPA

Developmental Neurotoxicity Screening